Aphrodisiac composition and management of male sexual dysfunction

A method for treating male sexual dysfunction in mammals comprising administering to a subject in need thereof an effective dose of a composition, wherein the composition comprises:

• 60-65% w/w Withania somnifera extract standardized to contain 0.25% withaferin and 7% withanolides,
• 12-18% w/w Mucana pruriens extract standardized to contain 10% w/w L-dopa,
• 5-10% w/w Coleus forskolii extract standardized to contain 10% w/w forskolin,
• 12-18% w/w Kaempferia parviflora standardized to contain 2.5% w/w of 5,7-dimethoxyflavone and not less than 10% w/w Total flavanoids and
• 0.1-2% w/w Piper nigrum extract standardized to contain 95% w/w piperine;
• wherein the male sexual dysfunction is selected from the group consisting of:
• erectile dysfunction, premature ejaculation, delayed or inhibited ejaculation, and reduced libido.